These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 35138223)

  • 1. N-Acetyltransferase 2, glutathione S-transferase gene polymorphisms and susceptibility to hepatocellular carcinoma in an Algerian population.
    Chorfi L; Fercha A; Derouiche F; Sebihi FZ; Houhou D; Chorfi K; Bendjemana K
    Xenobiotica; 2022 Jan; 52(1):99-104. PubMed ID: 35138223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-Acetyltransferase-2, glutathione S-transferase M1 and T1 genetic polymorphisms, cigarette smoking and hepatocellular carcinoma: a case-control study.
    Gelatti U; Covolo L; Talamini R; Tagger A; Barbone F; Martelli C; Cremaschini F; Franceschi S; Ribero ML; Garte S; Nardi G; Donadon V; Donato F
    Int J Cancer; 2005 Jun; 115(2):301-6. PubMed ID: 15688397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of NAT2, GSTM1, GSTT1, CYP2A6, and CYP2A13 gene polymorphisms with susceptibility and clinicopathologic characteristics of bladder cancer in Central China.
    Song DK; Xing DL; Zhang LR; Li ZX; Liu J; Qiao BP
    Cancer Detect Prev; 2009; 32(5-6):416-23. PubMed ID: 19303722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutathione S-transferase and N-acetyltransferase genotypes and asbestos-associated pulmonary disorders.
    Hirvonen A; Saarikoski ST; Linnainmaa K; Koskinen K; Husgafvel-Pursiainen K; Mattson K; Vainio H
    J Natl Cancer Inst; 1996 Dec; 88(24):1853-6. PubMed ID: 8961976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of NAT2, GSTT1, and GSTM1 gene polymorphisms withprostate cancer risk in Bangladeshi population.
    Nesa A; Mostafijur Rahman M; Tahminur Rahman M; Kabir Y
    Gene; 2023 Jun; 868():147368. PubMed ID: 36963735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glutathione S-transferase (GST) M1, T1 and N-acetyltransferase 2 (NAT2) polymorphisms and urothelial cancer risk with tobacco smoking.
    Tsukino H; Nakao H; Kuroda Y; Imai H; Inatomi H; Osada Y; Katoh T
    Eur J Cancer Prev; 2004 Dec; 13(6):509-14. PubMed ID: 15548945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modifying Effect of Smoking on GSTM1 and NAT2 in Relation to the Risk of Bladder Cancer in Mongolian Population: A Case-Control Study.
    Avirmed S; Khuanbai Y; Sanjaajamts A; Selenge B; Dagvadorj BU; Ohashi M
    Asian Pac J Cancer Prev; 2021 Aug; 22(8):2479-2485. PubMed ID: 34452561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined effect of smoking and inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1 on bladder cancer in a Tunisian population.
    Rouissi K; Ouerhani S; Marrakchi R; Ben Slama MR; Sfaxi M; Ayed M; Chebil M; El Gaaied AB
    Cancer Genet Cytogenet; 2009 Apr; 190(2):101-7. PubMed ID: 19380028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-acetyltransferase (NAT1, NAT2) and glutathione S-transferase (GSTM1, GSTT1) polymorphisms in breast cancer.
    Lee KM; Park SK; Kim SU; Doll MA; Yoo KY; Ahn SH; Noh DY; Hirvonen A; Hein DW; Kang D
    Cancer Lett; 2003 Jul; 196(2):179-86. PubMed ID: 12860276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glutathione S-transferase mu1 and N-acetyltransferase 2 genetic polymorphisms and exposure to tobacco smoke in nonsmoking and smoking lung cancer patients and population controls.
    Nyberg F; Hou SM; Hemminki K; Lambert B; Pershagen G
    Cancer Epidemiol Biomarkers Prev; 1998 Oct; 7(10):875-83. PubMed ID: 9796632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alcohol dehydrogenase 3, glutathione S-transferase M1 and T1 polymorphisms, alcohol consumption and hepatocellular carcinoma (Italy).
    Covolo L; Gelatti U; Talamini R; Garte S; Trevisi P; Franceschi S; Franceschini M; Barbone F; Tagger A; Ribero ML; Parrinello G; Donadon V; Nardi G; Donato F
    Cancer Causes Control; 2005 Sep; 16(7):831-8. PubMed ID: 16132793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses.
    García-Closas M; Malats N; Silverman D; Dosemeci M; Kogevinas M; Hein DW; Tardón A; Serra C; Carrato A; García-Closas R; Lloreta J; Castaño-Vinyals G; Yeager M; Welch R; Chanock S; Chatterjee N; Wacholder S; Samanic C; Torà M; Fernández F; Real FX; Rothman N
    Lancet; 2005 Aug 20-26; 366(9486):649-59. PubMed ID: 16112301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactive effect of glutathione S-transferase M1 and T1 polymorphisms on hepatocellular carcinoma.
    Sui C; Ma J; He X; Wang G; Ai F
    Tumour Biol; 2014 Aug; 35(8):8235-41. PubMed ID: 24852428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking.
    Okkels H; Sigsgaard T; Wolf H; Autrup H
    Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):225-31. PubMed ID: 9107426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic polymorphisms of phase II metabolic enzymes and lung cancer susceptibility in a population of Central South China.
    Chen HC; Cao YF; Hu WX; Liu XF; Liu QX; Zhang J; Liu J
    Dis Markers; 2006; 22(3):141-52. PubMed ID: 16788248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genotype and allele frequencies of N-acetyltransferase 2 and glutathione S-transferase in the Iranian population.
    Torkaman-Boutorabi A; Hoormand M; Naghdi N; Bakhshayesh M; Milanian I
    Clin Exp Pharmacol Physiol; 2007 Nov; 34(11):1207-11. PubMed ID: 17880378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphisms of glutathione-S-transferase and arylamine N-acetyltransferase enzymes and susceptibility to colorectal cancer.
    Kiss I; Németh A; Bogner B; Pajkos G; Orsós Z; Sándor J; Csejtey A; Faluhelyi Z; Rodler I; Ember I
    Anticancer Res; 2004; 24(6):3965-70. PubMed ID: 15736440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphisms of N-acetyltransferase 2, glutathione S-transferase mu and theta genes as risk factors of bladder cancer in relation to asthma and tuberculosis.
    Kim WJ; Lee HL; Lee SC; Kim YT; Kim H
    J Urol; 2000 Jul; 164(1):209-13. PubMed ID: 10840461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of DNA and protein adducts in smokers by genetic polymorphisms in GSTM1,GSTT1, NAT1 and NAT2.
    Godschalk RW; Dallinga JW; Wikman H; Risch A; Kleinjans JC; Bartsch H; Van Schooten FJ
    Pharmacogenetics; 2001 Jul; 11(5):389-98. PubMed ID: 11470992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Talc use, variants of the GSTM1, GSTT1, and NAT2 genes, and risk of epithelial ovarian cancer.
    Gates MA; Tworoger SS; Terry KL; Titus-Ernstoff L; Rosner B; De Vivo I; Cramer DW; Hankinson SE
    Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2436-44. PubMed ID: 18768514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.